Artelo Biosciences annual free cash flow
2018
2019
Artelo Biosciences Free Cash Flow (FCF) History (ARTL)
Artelo Biosciences reported −$2.8M in free cash flow for fiscal 2019, a decrease of $1.2M from the previous fiscal year.
View full Artelo Biosciences company overviewArtelo Biosciences free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2019 | 2019-08-31 | −$2.8M | −$1.2M | — | — |
| 2018 | 2018-08-31 | −$1.6M | — | — | — |
Artelo Biosciences quarterly free cash flow
Q1.18
Q2.18
Q3.18
Q4.18
Q3.20
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2020 | 2020-05-31 | −$1.0M | −$849,797 | — | — |
| Q4 2018 | 2018-08-31 | −$513,914 | — | — | — |
| Q3 2018 | 2018-05-31 | −$458,769 | — | — | — |
| Q2 2018 | 2018-02-28 | −$467,510 | — | — | — |
| Q1 2018 | 2017-11-30 | −$170,756 | — | — | — |
Artelo Biosciences free cash flow growth trends
Artelo Biosciences's latest reported quarter, Q3 2020, generated −$1.0M in free cash flow, a decrease of $849,797 year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Artelo Biosciences filings at SEC.gov ↗